The Technical Analyst
electroCore, Inc. [ECOR]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
electroCore, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.36% $5.64
America/New_York / 18 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 33.85 mill |
| EPS: | -3.42 |
| P/E: | -1.650 |
| Earnings Date: | May 01, 2024 |
| SharesOutstanding: | 6.00 mill |
| Avg Daily Volume: | 0.0118 mill |
| RATING 2024-04-18 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Neutral | |
| P/E: | Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -1.650 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.01x |
| Company: PE -1.650 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 5.43 - 6.15 ( +/- 6.18%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-01-16 | Goldberger Daniel S | Buy | 75 000 | Common Stock |
| 2024-01-12 | Posner Brian M | Buy | 16 000 | Common Stock |
| 2024-01-01 | Theofilos Charles Steve | Buy | 25 210 | Common Stock |
| 2023-12-08 | Theofilos Charles Steve | Sell | 0 | Common Stock |
| 2023-12-08 | Theofilos Charles Steve | Buy | 0 | Common Stock |
| INSIDER POWER |
|---|
| 100.00 |
| Last 93 transactions |
| Buy: 5 593 347 | Sell: 60 242 |
Forecast:
16:00 - $5.79
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $5.79
Forecast 2: 16:00 - $5.79
Forecast 3: 16:00 - $5.79
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $5.64 (0.36% ) |
| Volume | 0.0057 mill |
| Avg. Vol. | 0.0118 mill |
| % of Avg. Vol | 48.53 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For ECOR
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
ECOR
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Latest Press Releases
2024-04-08 08:30:00 - Press Release
Electrocore Announces The Launch Of Truvaga Plus® For General Wellness
Rockaway, n.j., april 08, 2024 (globe newswire) -- electrocore, inc. (nasdaq: ecor), a commercial-stage bioelectronic medicine and wellness company, today announced the launch of its direct-to-consumer mobile app-enabled product for general wellness, truvaga plus, which will be available on www.truvaga.com beginning april 8, 2024.
2024-04-02 08:00:00 - Press Release
Electrocore Expands Intellectual Property Portfolio
Rockaway, n.j., april 02, 2024 (globe newswire) -- electrocore, inc. (nasdaq: ecor), a commercial-stage bioelectronic medicine and wellness company, today announced that it has received patent issue notifications from the united states patent and trademark office (uspto).
2024-03-13 16:05:00 - Press Release
Electrocore Announces Fourth Quarter And Full Year 2023 financial Results
Record full year 2023 net sales of $ 16.0 million increased 87% over $8.6 million for the full year 2022
2024-03-12 08:00:00 - Press Release
Electrocore To Participate In Upcoming Investor Conferences
Rockaway, n.j., march 12, 2024 (globe newswire) -- electrocore, inc. (nasdaq: ecor), a commercial-stage bioelectronic medicine and wellness company, announced today that the company's chief strategy officer, joshua lev, is scheduled to attend the 36th annual roth conference taking place at the ritz carlton laguna niguel in dana point, california on march 17 – 19, 2024. electrocore will host 1x1 investor meetings on march 18 and 19, 2024. please contact roth mkm to schedule a 1x1 meeting.
2024-03-05 16:05:00 - Press Release
Electrocore To Announce Fourth Quarter And Full Year Ended December 31, 2023 Financial Results On Wednesday, March 13, 2024
Rockaway, n.j., march 05, 2024 (globe newswire) -- electrocore, inc. (nasdaq: ecor), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the fourth quarter and year ended december 31, 2023, after the close of the market on wednesday, march 13, 2024. management will host a conference call and webcast at 4:30 pm est to discuss the financial results and answer questions.
Latest News
2024-03-13 20:15:04 - Seeking Alpha
electroCore, Inc. (ECOR) Q4 2023 Earnings Call Transcript
2024-03-13 18:26:13 - Zacks Investment Research
ElectroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates
ElectroCore, Inc. (ECOR) came out with a quarterly loss of $0.61 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to loss of $1.22 per share a year ago.
2024-03-05 16:05:00 - GlobeNewsWire
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024
ROCKAWAY, N.J., March 05, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the fourth quarter and year ended December 31, 2023, after the close of the market on Wednesday, March 13, 2024. Management will host a conference call and webcast at 4:30 PM EST to discuss the financial results and answer questions.
2023-11-08 22:27:04 - Seeking Alpha
electroCore, Inc. (ECOR) Q3 2023 Earnings Call Transcript
electroCore, Inc. (NASDAQ:ECOR ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Dan Goldberger – Chief Executive Officer Brian Posner – Chief Financial Officer Conference Call Participants Destiny Hance – Ladenburg Thalmann Ramakanth Swayampakula – H.C. Wainwright Nick Sherwood – Maxim Group, LLC Walter Schenker – MAZ Partners Operator Greetings, and welcome to the electroCore Third Quarter 2023 Earnings Conference Call.
2023-10-09 08:00:00 - GlobeNewsWire
electroCore to Announce Third Quarter Financial Results on Wednesday, November 8
ROCKAWAY, N.J., Oct. 09, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the third quarter ended September 30, 2023, after the close of the market on Wednesday, November 8, 2023. Management will host a conference call and webcast at 4:30 PM EST to discuss the financial results and answer questions.
2023-10-05 08:00:00 - GlobeNewsWire
electroCore to Participate in the Lytham Partners Fall 2023 Virtual Investor Conference
ROCKAWAY, N.J., Oct. 05, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, will be participating in the Lytham Partners Fall 2023 Investor Conference taking place virtually on Tuesday, October 17, 2023.
2023-09-21 08:00:00 - GlobeNewsWire
electroCore to Present at iAccess Alpha's – Top 10 Best Ideas from the Buyside Virtual Conference
ROCKAWAY, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, will present at iAccess Alpha's – Top 10 Best Ideas from the Buyside Virtual Conference. Mr. Goldberger will also be available for one-on-one meetings held throughout the conference on September 26 and 27, 2023.
2023-08-09 22:14:10 - Seeking Alpha
electroCore, Inc. (ECOR) Q2 2023 Earnings Call Transcript
electroCore, Inc. (NASDAQ:ECOR ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Daniel Goldberger - CEO & Director Brian Posner - CFO & Corporate Secretary Conference Call Participants John Vandermosten - Zacks Swayampakula Ramakanth - H.C. Wainwright & Co. Nick Sherwood - Maxim Tyler Bussian - Brookline Capital Markets Operator Greetings, and welcome to the electroCore Second Quarter 2023 Earnings Conference Call.
2023-05-03 23:41:06 - Seeking Alpha
electroCore, Inc. (ECOR) Q1 2023 Earnings Call Transcript
electroCore, Inc. (NASDAQ:ECOR ) Q1 2023 Earnings Conference Call May 3, 2023 4:30 PM ET Company Participants Nicole Jones - IR Dan Goldberger - Chief Executive Officer Brian Posner - Chief Financial Officer Conference Call Participants John Vandermosten - Zacks Small-Cap Research Ramakanth Swayampakula - H.C. Wainwright Kemp Dolliver - Brookline Capital Markets Nick Sherwood - Maxim Group Operator And welcome to the electroCore First Quarter 2023 Earnings Call.
2023-05-01 16:01:00 - GlobeNewsWire
electroCore to Participate at Annual Aegis Virtual Conference
ROCKAWAY, N.J., May 01, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR) a commercial-stage bioelectronic medicine and wellness company, today announced that electroCore's Chief Executive Officer, Dan Goldberger, will present at the Annual Aegis Virtual Conference being held May 2-4, 2023.